Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Nano-Pso Therapy Compared to Placebo in the Control of Vasomotor Symptomatology in Early Menopause

NCT06432816 is registered in ClinicalTrials.gov with Distribuidora Biolife SA de CV as lead sponsor.

NCT NCT06432816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06432816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Nano-Pso Therapy Compared to Placebo in the Control of Vasomotor Symptomatology in Early Menopause
Lead sponsor
Distribuidora Biolife SA de CV
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2024
Completion date
July 31, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menopause, vasomotor; syndrome